Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to determine whether DCVAC/OvCa added to chemotherapy may result in prolongation of Overall Survival (OS).


Clinical Trial Description

The purpose of this study is to determine whether DCVAC/OvCa added to Standard of Care chemotherapy may result in prolongation of Overall Survival (OS). ;


Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT02107378
Study type Interventional
Source Sotio a.s.
Contact
Status Terminated
Phase Phase 2
Start date January 2014
Completion date August 2016

See also
  Status Clinical Trial Phase
Recruiting NCT05059444 - ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Recruiting NCT00349505 - Intraperitoneal Hyperthermic Chemotherapy in Epithelial Ovarian Carcinoma Phase 2
Recruiting NCT05470920 - Genetic Testing Decision Aid N/A
Recruiting NCT02611024 - Pharmacokinetic Study of Lurbinectedin in Combination With Irinotecan in Patients With Selected Solid Tumors Phase 1/Phase 2
Withdrawn NCT01138137 - N-acetylcysteine Given IV With Cisplatin and Paclitaxel in Patients With Ovarian Cancer Phase 1
Recruiting NCT02437812 - Study of Paclitaxel, Carboplatin and Oral Metformin in the Treatment of Advanced Stage Ovarian Carcinoma Phase 2
Recruiting NCT02344095 - A Trial of Weekly Paclitaxel With Oncothermia and Weekly cisPlatin With Oncothermia in Patients With Recurrent or Persistent Ovarian Cancer Phase 1
Recruiting NCT05086692 - A Beta-only IL-2 ImmunoTherapY Study Phase 1/Phase 2
Recruiting NCT04834544 - A Study of Maintenance DCVAC/OvCa After First-line Chemotherapy Added Standard of Care Phase 2